Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
innovation tags : Approval save search
UATP Receives Patent Approval for Innovative New Payment Technology
Published: 2024-02-15 (Crawled : 14:30) - prnewswire.com
DAL | $47.57 -0.59% 0.06% 9.2M
|
Transportation
|
| O: 0.86%
H: 0.56%
C: -0.46%
AAL | $14.1 0.57% 0.57% 27M
|
Transportation
|
| O: 1.08%
H: 0.83%
C: -0.8%
patent approval payment technology
Maris-Tech Receives Grant Approval in the Amount of Approximately $156,000 from the Israel Innovation Authority for the Second Year of a Joint Development Project with the Ben Gurion University
Published: 2023-11-03 (Crawled : 12:00) - globenewswire.com
MTEK | $1.54 2.67% 2.6% 26K
|
|
| O: -2.87%
H: 2.0%
C: 1.0%
israel year approval innovation grant
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
Published: 2023-08-17 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.95%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.96%
H: 0.35%
C: -0.9%
sintbilo approval treatment hypercholesterolemia
SS Innovations Begins FDA and CE Regulatory Approval Processes for SSi Mantra Flagship Surgical Robotic Device
Published: 2023-08-02 (Crawled : 11:00) - globenewswire.com
SSII | $5.95 3.7% 1.7K
|
n/a
|
| O: 0.32%
H: 0.0%
C: -0.64%
fda device approval
Bubblr Inc. Announces the Submission of Innovative AI Seek App to Apple and Google Stores for Approval
Published: 2023-07-17 (Crawled : 15:00) - globenewswire.com
BBLR | $0.0271 75.14% 1.5K
|
n/a
|
| O: 0.0%
H: 17.91%
C: 0.0%
apple approval submission
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
Published: 2023-07-03 (Crawled : 00:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.24%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.16%
H: 0.6%
C: -0.11%
fucaso approval treatment car-t
IASO Bio and Innovent Announce the NMPA Approval of the New Drug Application for Equecabtagene Autoleucel, the World's First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2023-07-03 (Crawled : 00:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.24%
H: 0.0%
C: 0.0%
drug approval treatment application car-t
BlackSwan Vascular Wins FDA Premarket Approval of Innovative New Treatment for Peripheral Arterial Hemorrhages
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
fda approval treatment
North America Disposable Endoscopes Market Report 2022-2030: Increasing Regulatory Approval & Manufacturer Innovation to Create Future Opportunities
Published: 2022-07-28 (Crawled : 12:00) - prnewswire.com
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.12%
H: 2.89%
C: 2.24%
america report approval innovation market
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2022-06-27 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.36%
H: 0.35%
C: -0.71%
tyvyt treatment approval china
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
Published: 2022-06-21 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 5.74%
H: 0.0%
C: 0.0%
tyvyt treatment approval china cell carcinoma
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar) by the Indonesian Food and Drugs Authority (BPOM)
Published: 2022-06-14 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.09%
H: 0.41%
C: -1.96%
bevagen approval food drug
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma
Published: 2022-04-06 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.23%
H: 3.54%
C: 3.29%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.47%
H: 2.2%
C: 1.93%
pemazyre treatment approval
Innovative Payment Solutions, Inc. Launches Second Phase of IPSIPay App with Approval for its VISA Debit Card
Published: 2022-04-04 (Crawled : 13:20) - globenewswire.com
IPSI | $0.1484 -92.67% 170
|
Retail Trade
|
| O: 12.99%
H: 0.0%
C: -15.0%
approval payment
HUTCHMED Receives Approval to Commercialize ELUNATE® in MacauFirst homegrown innovative medicine approved in Macau based on China clinical data
Published: 2022-03-01 (Crawled : 11:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
elunate approval china commercialization
Greenlight Re Innovations Receives In-Principle Approval to Establish Insurtech-focused Syndicate 3456
Published: 2022-01-31 (Crawled : 13:30) - globenewswire.com
GLRE 4 | $12.415 1.35% 1.33% 42K
|
Finance
|
| O: 0.28%
H: 2.25%
C: 1.97%
approval
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma
Published: 2022-01-24 (Crawled : 12:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.97%
H: 0.5%
C: -0.88%
pemazyre treatment ema ces approval
SCYNEXIS Announces Agreement with FDA on Innovative Strategy for Approval of Oral Ibrexafungerp for Treatment of Invasive Candidiasis
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
SCYX | $1.44 2.49% 2.43% 130K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
treatment fda approval
Johnson Controls files 200th U.S. Patent Application and receives 90th U.S. patent approval for OpenBlue Energy Optimization Innovations
Published: 2021-07-26 (Crawled : 11:00) - prnewswire.com
CLVT | $6.99 0.58% 0.0% 4.1M
|
Information
|
| O: -0.99%
H: 0.48%
C: -2.32%
JCI | News | $63.66 -0.17% 0.0% 5.2M
|
Producer Manufacturing
|
| O: 0.3%
H: 0.32%
C: -0.3%
energy patent approval application
Almirall receives European Commission approval of Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis
Published: 2021-07-19 (Crawled : 21:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: -2.26%
H: 1.8%
C: -0.77%
treatment actinic keratosis europe approval tirbanibulin
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.